Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Riederer

Showing results (361-370 of 587) with videos related to

Pageof 59
Sort By:
Journal of Neurology|February 24, 2001
Workshop II: "neuroprotection"--the Lugano consensusP Riederer, T Brücke, C Buhmann, et al.
Journal of Neural Transmission. Supplementum|January 1, 1990
Brofaromine (CGP 11 305 A): estimation of plasma concentrations by a biologic technique as compared to liquid chromatographyJ Fritze, T Becker, V Ziegler, et al.
Neurochemistry International|May 28, 2010
Milacemide, the selective substrate and enzyme-activated specific inhibitor of monoamine oxidase B, increases dopamine but not serotonin in caudate nucleus of rhesus monkeyP Janssens de Varebeke, E Schallauer, W D Rausch, et al.
Alcoholism, Clinical and Experimental Research|December 1, 1996
Alteration of glutamyltranspeptidase binding proteins in postmortem brains of heroin addictsE Hashimoto, L Frölich, H Ozawa, et al.
Journal of Affective Disorders|May 1, 1991
Lymphocyte glucocorticoid receptor binding during depression and after clinical recoveryR Rupprecht, J Kornhuber, N Wodarz, et al.
Cell and Tissue Research|April 16, 2018
Lateralisation in Parkinson diseaseP Riederer, K A Jellinger, P Kolber, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1991
A study of brain dopamine sulfate levels in relation to free dopamine and homovanillic acid in Parkinson's diseaseE Sofic, P Riederer, W Wesemann, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1994
Quantification of mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the substantia nigra in Parkinson's disease and schizophreniaH Ichinose, T Ohye, K Fujita, et al.
Journal of Medicinal Chemistry|February 17, 1998
Quantitative analysis of the structural requirements for blockade of the N-methyl-D-aspartate receptor at the phencyclidine binding siteR T Kroemer, E Koutsilieri, P Hecht, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1990
Changes in pyruvate dehydrogenase complex (PDHc) activity and [3H]QNB-receptor binding in rat brain subsequent to intracerebroventricular injection of bromopyruvateL Frölich, M Strauss, J Kornhuber, et al.
Pageof 59

Showing results (361-370 of 587) with videos related to

Sort By:
Pageof 59
Journal of Neurology|February 24, 2001
Workshop II: "neuroprotection"--the Lugano consensusP Riederer, T Brücke, C Buhmann, et al.
Journal of Neural Transmission. Supplementum|January 1, 1990
Brofaromine (CGP 11 305 A): estimation of plasma concentrations by a biologic technique as compared to liquid chromatographyJ Fritze, T Becker, V Ziegler, et al.
Neurochemistry International|May 28, 2010
Milacemide, the selective substrate and enzyme-activated specific inhibitor of monoamine oxidase B, increases dopamine but not serotonin in caudate nucleus of rhesus monkeyP Janssens de Varebeke, E Schallauer, W D Rausch, et al.
Alcoholism, Clinical and Experimental Research|December 1, 1996
Alteration of glutamyltranspeptidase binding proteins in postmortem brains of heroin addictsE Hashimoto, L Frölich, H Ozawa, et al.
Journal of Affective Disorders|May 1, 1991
Lymphocyte glucocorticoid receptor binding during depression and after clinical recoveryR Rupprecht, J Kornhuber, N Wodarz, et al.
Cell and Tissue Research|April 16, 2018
Lateralisation in Parkinson diseaseP Riederer, K A Jellinger, P Kolber, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1991
A study of brain dopamine sulfate levels in relation to free dopamine and homovanillic acid in Parkinson's diseaseE Sofic, P Riederer, W Wesemann, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1994
Quantification of mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the substantia nigra in Parkinson's disease and schizophreniaH Ichinose, T Ohye, K Fujita, et al.
Journal of Medicinal Chemistry|February 17, 1998
Quantitative analysis of the structural requirements for blockade of the N-methyl-D-aspartate receptor at the phencyclidine binding siteR T Kroemer, E Koutsilieri, P Hecht, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1990
Changes in pyruvate dehydrogenase complex (PDHc) activity and [3H]QNB-receptor binding in rat brain subsequent to intracerebroventricular injection of bromopyruvateL Frölich, M Strauss, J Kornhuber, et al.
Pageof 59